368 related articles for article (PubMed ID: 32487559)
1. Endogenous miR-204 Protects the Kidney against Chronic Injury in Hypertension and Diabetes.
Cheng Y; Wang D; Wang F; Liu J; Huang B; Baker MA; Yin J; Wu R; Liu X; Regner KR; Usa K; Liu Y; Zhang C; Dong L; Geurts AM; Wang N; Miller SS; He Y; Liang M
J Am Soc Nephrol; 2020 Jul; 31(7):1539-1554. PubMed ID: 32487559
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-214-3p in the Kidney Contributes to the Development of Hypertension.
Liu Y; Usa K; Wang F; Liu P; Geurts AM; Li J; Williams AM; Regner KR; Kong Y; Liu H; Nie J; Liang M
J Am Soc Nephrol; 2018 Oct; 29(10):2518-2528. PubMed ID: 30049682
[TBL] [Abstract][Full Text] [Related]
3. MiR-192-5p in the Kidney Protects Against the Development of Hypertension.
Baker MA; Wang F; Liu Y; Kriegel AJ; Geurts AM; Usa K; Xue H; Wang D; Kong Y; Liang M
Hypertension; 2019 Feb; 73(2):399-406. PubMed ID: 30595117
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-122-5p promotes renal fibrosis and injury in spontaneously hypertensive rats by targeting FOXO3.
Liu Y; Dong ZJ; Song JW; Liang LR; Sun LL; Liu XY; Miao R; Xu YL; Li XT; Zhang MW; Zhang ZZ; Zhong JC
Exp Cell Res; 2022 Feb; 411(2):113017. PubMed ID: 34998813
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-184 is a downstream effector of albuminuria driving renal fibrosis in rats with diabetic nephropathy.
Zanchi C; Macconi D; Trionfini P; Tomasoni S; Rottoli D; Locatelli M; Rudnicki M; Vandesompele J; Mestdagh P; Remuzzi G; Benigni A; Zoja C
Diabetologia; 2017 Jun; 60(6):1114-1125. PubMed ID: 28364255
[TBL] [Abstract][Full Text] [Related]
6. Silencing of long noncoding RNA XIST protects against renal interstitial fibrosis in diabetic nephropathy via microRNA-93-5p-mediated inhibition of CDKN1A.
Yang J; Shen Y; Yang X; Long Y; Chen S; Lin X; Dong R; Yuan J
Am J Physiol Renal Physiol; 2019 Nov; 317(5):F1350-F1358. PubMed ID: 31545928
[TBL] [Abstract][Full Text] [Related]
7. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
8. p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO.
Yang R; Xu X; Li H; Chen J; Xiang X; Dong Z; Zhang D
Sci Rep; 2017 Feb; 7():43409. PubMed ID: 28240316
[TBL] [Abstract][Full Text] [Related]
9. LncRNA MEG8 sponging miR-181a-5p contributes to M1 macrophage polarization by regulating SHP2 expression in Henoch-Schonlein purpura rats.
Jiang M; Dai J; Yin M; Jiang C; Ren M; Tian L
Ann Med; 2021 Dec; 53(1):1576-1588. PubMed ID: 34477472
[TBL] [Abstract][Full Text] [Related]
10. MiR-32-5p knockdown inhibits epithelial to mesenchymal transition and renal fibrosis by targeting SMAD7 in diabetic nephropathy.
Wang HJ; Liu H; Lin YH; Zhang SJ
Hum Exp Toxicol; 2021 Apr; 40(4):587-595. PubMed ID: 32959695
[TBL] [Abstract][Full Text] [Related]
11. HNRNPA1-mediated exosomal sorting of miR-483-5p out of renal tubular epithelial cells promotes the progression of diabetic nephropathy-induced renal interstitial fibrosis.
Liu D; Liu F; Li Z; Pan S; Xie J; Zhao Z; Liu Z; Zhang J; Liu Z
Cell Death Dis; 2021 Mar; 12(3):255. PubMed ID: 33692334
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting microRNA-192 ameliorates renal fibrosis in diabetic nephropathy.
Putta S; Lanting L; Sun G; Lawson G; Kato M; Natarajan R
J Am Soc Nephrol; 2012 Mar; 23(3):458-69. PubMed ID: 22223877
[TBL] [Abstract][Full Text] [Related]
13. Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes.
Liu Y; Taylor NE; Lu L; Usa K; Cowley AW; Ferreri NR; Yeo NC; Liang M
Hypertension; 2010 Apr; 55(4):974-82. PubMed ID: 20194304
[TBL] [Abstract][Full Text] [Related]
14. miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes.
Zhong X; Chung AC; Chen HY; Dong Y; Meng XM; Li R; Yang W; Hou FF; Lan HY
Diabetologia; 2013 Mar; 56(3):663-74. PubMed ID: 23292313
[TBL] [Abstract][Full Text] [Related]
15. Variations in MicroRNA-25 Expression Influence the Severity of Diabetic Kidney Disease.
Liu Y; Li H; Liu J; Han P; Li X; Bai H; Zhang C; Sun X; Teng Y; Zhang Y; Yuan X; Chu Y; Zhao B
J Am Soc Nephrol; 2017 Dec; 28(12):3627-3638. PubMed ID: 28923913
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction.
Schauerte C; Hübner A; Rong S; Wang S; Shushakova N; Mengel M; Dettling A; Bang C; Scherf K; Koelling M; Melk A; Haller H; Thum T; Lorenzen JM
Kidney Int; 2017 Sep; 92(3):646-656. PubMed ID: 28396121
[TBL] [Abstract][Full Text] [Related]
17. MiR-135a promotes renal fibrosis in diabetic nephropathy by regulating TRPC1.
He F; Peng F; Xia X; Zhao C; Luo Q; Guan W; Li Z; Yu X; Huang F
Diabetologia; 2014 Aug; 57(8):1726-36. PubMed ID: 24908566
[TBL] [Abstract][Full Text] [Related]
18. miR-486-5p protects against rat ischemic kidney injury and prevents the transition to chronic kidney disease and vascular dysfunction.
Douvris A; Viñas JL; Gutsol A; Zimpelmann J; Burger D; Burns KD
Clin Sci (Lond); 2024 May; 138(10):599-614. PubMed ID: 38739452
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension.
Krishnan SM; Ling YH; Huuskes BM; Ferens DM; Saini N; Chan CT; Diep H; Kett MM; Samuel CS; Kemp-Harper BK; Robertson AAB; Cooper MA; Peter K; Latz E; Mansell AS; Sobey CG; Drummond GR; Vinh A
Cardiovasc Res; 2019 Mar; 115(4):776-787. PubMed ID: 30357309
[TBL] [Abstract][Full Text] [Related]
20. Renal Tumor Necrosis Factor α Contributes to Hypertension in Dahl Salt-Sensitive Rats.
Huang B; Cheng Y; Usa K; Liu Y; Baker MA; Mattson DL; He Y; Wang N; Liang M
Sci Rep; 2016 Feb; 6():21960. PubMed ID: 26916681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
